Acrobat New

Primær information

  • Handelsnavn:
  • Acrobat New Vanddispergerbart granulat
  • Lægemiddelform:
  • Vanddispergerbart granulat
  • Sammensætning:
  • 75 g/kg dimethomorph; 667 g/kg mancozeb
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • Acrobat New Vanddispergerbart granulat
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Markedsført
  • Autorisationsnummer:
  • 19-222
  • Sidste ændring:
  • 08-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

20-4-2018

FDA authorizes new use of test, first to identify the emerging pathogen <i>Candida auris</i>

FDA authorizes new use of test, first to identify the emerging pathogen <i>Candida auris</i>

FDA authorized the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalized patients.

FDA - U.S. Food and Drug Administration

20-4-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder

FDA announces new steps to encourage more widespread innovation and development of new treatments for opioid use disorder

FDA - U.S. Food and Drug Administration

20-4-2018

FDA takes new steps to advance the development of innovative products for treating opioid use disorder

FDA takes new steps to advance the development of innovative products for treating opioid use disorder

FDA announces new steps to encourage and support the development of treatment options for people with opioid use disorder

FDA - U.S. Food and Drug Administration

20-4-2018

Eataly USA Issues Allergy Alert on Undeclared Walnuts in Artichoke Spread

Eataly USA Issues Allergy Alert on Undeclared Walnuts in Artichoke Spread

Eataly USA of New York City, New York is recalling Eataly Artichoke Spread, because it may contain undeclared walnuts. People who have an allergy or severe sensitivity to walnuts run the risk of serious or life-threatening allergic reaction if they consume these products.

FDA - U.S. Food and Drug Administration

19-4-2018

April 6, 2018: New Hampshire Residents Sentenced for Participating in Scheme to Distribute Misbranded Drugs

April 6, 2018: New Hampshire Residents Sentenced for Participating in Scheme to Distribute Misbranded Drugs

April 6, 2018: New Hampshire Residents Sentenced for Participating in Scheme to Distribute Misbranded Drugs

FDA - U.S. Food and Drug Administration

17-4-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation

The FDA is releasing the Medical Device Safety Action Plan that outlines our vision for how FDA can continue to enhance our programs and processes to assure the safety of medical devices

FDA - U.S. Food and Drug Administration

10-4-2018

Nine Whole Foods Market Stores Issue Voluntary Recall for Explorateur French Triple Creme Cheese Due to Possible Health Risk

Nine Whole Foods Market Stores Issue Voluntary Recall for Explorateur French Triple Creme Cheese Due to Possible Health Risk

Whole Foods Market is voluntarily recalling Explorateur French Triple Crème cheese from nine stores located in New Mexico, Texas, Arkansas, Illinois, Connecticut and New Jersey out of an abundance of caution. The cheese has the potential to be contaminated with Listeria monocytogenes.

FDA - U.S. Food and Drug Administration

3-4-2018

CVM releases eSubmitter Webinar Series

CVM releases eSubmitter Webinar Series

Beginning on May 23, 2018, the Center for Veterinary Medicine (CVM) will host a three-part webinar series to provide information on the new animal drug application approval process.

FDA - U.S. Food and Drug Administration

3-4-2018

Three new reimbursement guidelines

Three new reimbursement guidelines

The Danish Medicines Agency has issued three new guidelines on reimbursement (in Danish only). This regards Guideline on application for general reimbursement and general conditional reimbursement, Guideline on periodic reassessment of the reimbursement status of medicines and Guideline on the making of health economic analyses of medicines.

Danish Medicines Agency

2-4-2018

New York raw milk cheese company ordered to stop sales for food safety violations

New York raw milk cheese company ordered to stop sales for food safety violations

FDA announces an enforcement action taken against Vulto Creamery of New York. The company cannot sell ready-to-eat raw cheese product until it complies with the consent decree. Vulto was linked to an outbreak last year.

FDA - U.S. Food and Drug Administration

29-3-2018

Federal judge approves consent decree with New York dietary supplement manufacturer Riddhi USA

Federal judge approves consent decree with New York dietary supplement manufacturer Riddhi USA

A New York dietary supplement manufacturer has been ordered by a federal court to stop selling its products until the company comes into compliance with the FDA’s dietary supplement manufacturing regulations.

FDA - U.S. Food and Drug Administration

28-3-2018

Federal judge approves consent decree with Florida company that sold unapproved new drugs and misbranded drugs

Federal judge approves consent decree with Florida company that sold unapproved new drugs and misbranded drugs

Federal judge approves consent decree with Florida company that sold unapproved new drugs and misbranded drugs

FDA - U.S. Food and Drug Administration

28-3-2018

Foot-and-mouth disease: a new international reference mandate for ANSES

Foot-and-mouth disease: a new international reference mandate for ANSES

Through its Maisons-Alfort Laboratory for Animal Health, ANSES has just been appointed Reference Centre of the Food and Agriculture Organisation of the United Nations (FAO) for foot-and-mouth disease and vesicular diseases. This new mandate expands the reference activities of the Maisons-Alfort Laboratory for Animal Health regarding foot-and-mouth disease, particularly in the context of its reference mandates at a national, European and international level, and is recognition of ANSES's commitment to add...

France - Agence Nationale du Médicament Vétérinaire

26-3-2018

Health Canada warns of safety hazards with several uncertified USB chargers

Health Canada warns of safety hazards with several uncertified USB chargers

As part of a planned national sampling and compliance project, Health Canada tested a number of uncertified USB chargers. The following products were found to pose an unacceptable risk of electric shock and fire and are being recalled. This table will be updated if and when new products are recalled.

Health Canada

23-3-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on a key step in advancing FDA’s oversight of drug compounding and implementing new laws governing outsourcing facilities

Statement from FDA Commissioner Scott Gottlieb, M.D., on a key step in advancing FDA’s oversight of drug compounding and implementing new laws governing outsourcing facilities

Statement from FDA Commissioner Scott Gottlieb, M.D., on a key step in advancing FDA’s oversight of drug compounding and implementing new laws governing outsourcing facilities

FDA - U.S. Food and Drug Administration

20-4-2018

News and press releases:  Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-19 April 2018

News and press releases: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-19 April 2018

CVMP adopts new guideline on user safety of topically applied veterinary medicines

Europe - EMA - European Medicines Agency

20-4-2018

The Poisons Standard and medical devices

The Poisons Standard and medical devices

New guidance explaining the labelling requirements of medical devices containing poisons

Therapeutic Goods Administration - Australia

19-4-2018

New Therapy May Prevent Tough-to-Treat Migraines

New Therapy May Prevent Tough-to-Treat Migraines

Title: New Therapy May Prevent Tough-to-Treat MigrainesCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/18/2018 12:00:00 AM

US - MedicineNet

18-4-2018

New Drugs May Be Big Advance in Lung Cancer Care

New Drugs May Be Big Advance in Lung Cancer Care

Title: New Drugs May Be Big Advance in Lung Cancer CareCategory: Health NewsCreated: 4/16/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Prolonged Sitting Tied to Brain Atrophy

Prolonged Sitting Tied to Brain Atrophy

Prolonged periods of sitting in middle age is tied to brain atrophy, new research shows.

US - RxList

17-4-2018

ACSS - NCE work-sharing pilot

ACSS - NCE work-sharing pilot

New work-sharing initiative through ACSS consortium

Therapeutic Goods Administration - Australia

16-4-2018

HYDROCODONE BITARTRATE AND IBUPROFEN Tablet [Amneal Pharmaceuticals Of New York LLC]

HYDROCODONE BITARTRATE AND IBUPROFEN Tablet [Amneal Pharmaceuticals Of New York LLC]

Updated Date: Apr 16, 2018 EST

US - DailyMed

13-4-2018

News and press releases:  Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 April 2018

News and press releases: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 April 2018

PRAC starts new referral on methotrexate

Europe - EMA - European Medicines Agency

13-4-2018

NEW DAY (Levonorgestrel) Tablet [Northstar Rx LLC]

NEW DAY (Levonorgestrel) Tablet [Northstar Rx LLC]

Updated Date: Apr 13, 2018 EST

US - DailyMed

12-4-2018

VITAMIN A AND D (Lanolin, Petrolatum) Ointment [Perrigo New York Inc]

VITAMIN A AND D (Lanolin, Petrolatum) Ointment [Perrigo New York Inc]

Updated Date: Apr 12, 2018 EST

US - DailyMed

11-4-2018

News and press releases:  Redistribution of UK’s portfolio of centrally authorised products

News and press releases: Redistribution of UK’s portfolio of centrally authorised products

Assignment of new rapporteurs and co-rapporteurs completed

Europe - EMA - European Medicines Agency

11-4-2018

FDA Puts New Restrictions on Contraceptive Implant Essure

FDA Puts New Restrictions on Contraceptive Implant Essure

Title: FDA Puts New Restrictions on Contraceptive Implant EssureCategory: Health NewsCreated: 4/9/2018 12:00:00 AMLast Editorial Review: 4/10/2018 12:00:00 AM

US - MedicineNet

9-4-2018

TRUE COLOR IDEAL NUDE MATTE FOUNDATION SPF20 Lotion [New Avon LLC]

TRUE COLOR IDEAL NUDE MATTE FOUNDATION SPF20 Lotion [New Avon LLC]

Updated Date: Apr 9, 2018 EST

US - DailyMed

9-4-2018

TRUE COLOR FLAWLESS CREAM TO POWDER FOUNDATION SPF15 Cream [New Avon LLC]

TRUE COLOR FLAWLESS CREAM TO POWDER FOUNDATION SPF15 Cream [New Avon LLC]

Updated Date: Apr 9, 2018 EST

US - DailyMed

9-4-2018

TRUE COLOR FLAWLESS LIQUID FOUNDATION SPF15 Lotion [New Avon LLC]

TRUE COLOR FLAWLESS LIQUID FOUNDATION SPF15 Lotion [New Avon LLC]

Updated Date: Apr 9, 2018 EST

US - DailyMed

9-4-2018

ACV meeting statement, Meeting 3, 2 August 2017

ACV meeting statement, Meeting 3, 2 August 2017

Section A: Submissions for registration The committee's advice was sought on one application for a new vaccine containing a new biological entity. The committee provided advice on a range of issues.

Therapeutic Goods Administration - Australia

7-4-2018

'Magnetic Pulse' Device May Be New Way to Prevent Migraines

'Magnetic Pulse' Device May Be New Way to Prevent Migraines

Title: 'Magnetic Pulse' Device May Be New Way to Prevent MigrainesCategory: Health NewsCreated: 4/5/2018 12:00:00 AMLast Editorial Review: 4/6/2018 12:00:00 AM

US - MedicineNet

7-4-2018

New Hope Against Disease That Brings a Colorless World

New Hope Against Disease That Brings a Colorless World

Title: New Hope Against Disease That Brings a Colorless WorldCategory: Health NewsCreated: 4/6/2018 12:00:00 AMLast Editorial Review: 4/6/2018 12:00:00 AM

US - MedicineNet

6-4-2018

Beta-Blockers May Raise Mortality in People With Diabetes

Beta-Blockers May Raise Mortality in People With Diabetes

Use of beta-blockers may be associated with an increased mortality risk in patients with diabetes, particularly among those who have coronary heart disease (CHD), new research suggests.

US - RxList

5-4-2018

New Autism Drug Being Tested in U.S.-Wide Trial

New Autism Drug Being Tested in U.S.-Wide Trial

Title: New Autism Drug Being Tested in U.S.-Wide TrialCategory: Health NewsCreated: 4/3/2018 12:00:00 AMLast Editorial Review: 4/4/2018 12:00:00 AM

US - MedicineNet

5-4-2018

Noisy Workplace Linked to Hypertension, Hyperlipidemia

Noisy Workplace Linked to Hypertension, Hyperlipidemia

Hypertension and hyperlipidemia are more common among workers exposed to loud noise in the workplace, suggests new research from the National Institute for Occupational Safety and Health (NIOSH), part of the Centers for Disease Control and Prevention (CDC).

US - RxList

3-4-2018

Older Age, Long-term Antibiotic Use Linked to Mortality Risk

Older Age, Long-term Antibiotic Use Linked to Mortality Risk

Older women who report longer-term use of antibiotics show increases in all-cause mortality and notably higher rates of cardiovascular mortality compared with those with no antibiotic use, after adjustment for illness and other risk factors, new research suggests.

US - RxList

2-4-2018

NUTRA EFFECTS AGELESS DAY CREAM SPF20 Cream [New Avon LLC]

NUTRA EFFECTS AGELESS DAY CREAM SPF20 Cream [New Avon LLC]

Updated Date: Apr 2, 2018 EST

US - DailyMed

2-4-2018

NUTRA EFFECTS BALANCE DAY CREAM SPF15 Cream [New Avon LLC]

NUTRA EFFECTS BALANCE DAY CREAM SPF15 Cream [New Avon LLC]

Updated Date: Apr 2, 2018 EST

US - DailyMed

2-4-2018

NUTRA EFFECTS HYDRATION DAY CREAM SPF15 Cream [New Avon LLC]

NUTRA EFFECTS HYDRATION DAY CREAM SPF15 Cream [New Avon LLC]

Updated Date: Apr 2, 2018 EST

US - DailyMed

30-3-2018

Nonphysical Problems Common After Stroke

Nonphysical Problems Common After Stroke

A new study highlights some of the more common nonphysical problems experienced by patients after they have an ischemic stroke, with some surprising findings.

US - RxList

29-3-2018

Scientists Say They Discovered a 'New Organ' in the Body

Scientists Say They Discovered a 'New Organ' in the Body

Title: Scientists Say They Discovered a 'New Organ' in the BodyCategory: Health NewsCreated: 3/27/2018 12:00:00 AMLast Editorial Review: 3/28/2018 12:00:00 AM

US - MedicineNet

29-3-2018

MRI Sheds New Light on Brain Networks Tied to Autism

MRI Sheds New Light on Brain Networks Tied to Autism

Title: MRI Sheds New Light on Brain Networks Tied to AutismCategory: Health NewsCreated: 3/27/2018 12:00:00 AMLast Editorial Review: 3/28/2018 12:00:00 AM

US - MedicineNet

29-3-2018

AZELASTINE HCL NASAL (Azelastine Hcl) Spray [Perrigo New York Inc]

AZELASTINE HCL NASAL (Azelastine Hcl) Spray [Perrigo New York Inc]

Updated Date: Mar 29, 2018 EST

US - DailyMed

29-3-2018

Application for an evaluation of a new complementary medicine substance

Application for an evaluation of a new complementary medicine substance

Update form and guidance

Therapeutic Goods Administration - Australia

29-3-2018

Codeine information hub: Codeine harm and efficacy literature

Codeine information hub: Codeine harm and efficacy literature

New codeine articles from MedicineToday available on the Codeine Information Hub

Therapeutic Goods Administration - Australia

28-3-2018

Courtney Lias and Stayce Beck paved the way for an automated insulin dosing system to receive FDA approval years earlier than expected, helping to make a groundbreaking new device for diabetes management available for Americans with Type 1 diabetes #Women

Courtney Lias and Stayce Beck paved the way for an automated insulin dosing system to receive FDA approval years earlier than expected, helping to make a groundbreaking new device for diabetes management available for Americans with Type 1 diabetes #Women

Courtney Lias and Stayce Beck paved the way for an automated insulin dosing system to receive FDA approval years earlier than expected, helping to make a groundbreaking new device for diabetes management available for Americans with Type 1 diabetes #WomensHistoryMonth pic.twitter.com/t1EyVQAh8t

FDA - U.S. Food and Drug Administration

27-3-2018

New Moms Still Wary of Exposing Infants to Peanuts

New Moms Still Wary of Exposing Infants to Peanuts

Title: New Moms Still Wary of Exposing Infants to PeanutsCategory: Health NewsCreated: 3/23/2018 12:00:00 AMLast Editorial Review: 3/26/2018 12:00:00 AM

US - MedicineNet

27-3-2018

Assessed listed medicines

Assessed listed medicines

The new assessed listed medicines pathway is now available

Therapeutic Goods Administration - Australia

27-3-2018

Assessed listed medicines guidelines

Assessed listed medicines guidelines

The new assessed listed medicines pathway is now available.

Therapeutic Goods Administration - Australia

26-3-2018

HYDROCORTISONE ACETATE PRAMOXINE HCL Cream [Perrigo New York Inc]

HYDROCORTISONE ACETATE PRAMOXINE HCL Cream [Perrigo New York Inc]

Updated Date: Mar 26, 2018 EST

US - DailyMed

23-3-2018

News and press releases:  New measures to avoid valproate exposure in pregnancy endorsed

News and press releases: New measures to avoid valproate exposure in pregnancy endorsed

Member State representatives agree new restrictions and pregnancy prevention programme

Europe - EMA - European Medicines Agency